First XP-V Patient Treated in CLINUVEL DNA Repair Study 2022 Announcements . Clinical . News 30.03.2022
Afamelanotide in stroke (AIS) – positive preliminary results 2022 Announcements . Clinical . News 15.03.2022
CLINUVEL Expands DNA Repair Program with 2nd DNA Repair Study 2022 Announcements . Clinical . News 14.02.2022
CLINUVEL completes enrolment in world-first stroke study 2022 Announcements . Clinical . News 17.01.2022
Afamelanotide well tolerated by first stroke patients 2021 Announcements . Clinical . News 10.08.2021
Insider Insights III: Willem Blijdorp – Challenges & the Future 2021 Announcements . Corporate . News . Presentation . Stories 14.07.2021
Insider Insights II: Willem Blijdorp – CLINUVEL’s Products, People & Social Purpose 2021 Announcements . Corporate . News . Presentation . Stories 07.07.2021
Insider Insights: Willem Blijdorp – Chair of The CLINUVEL Group 2021 Announcements . Corporate . News . Presentation . Stories 30.06.2021
Media Release – First stroke patient treated with afamelanotide 2021 Announcements . Clinical . News 07.06.2021